Convulsants Acting at the Inhibitory Glycine Receptor

  • C.-M. Becker
Part of the Springer Study Edition book series (volume 102)


Inhibitory neurotransmission in the CNS is predominantly mediated by γ-aminobutyric acid (GABA) and glycine. Whereas GABAergic synapses are abundant in the cortex and cerebellum, glycine predominates in the spinal cord and brain stem (reviewed by Betz and Becker 1988; Langosch et al. 1990a,b). Glycine-mediated synaptic inhibition was first demonstrated in the spinal cord where, at the segmental level, neuronal pathways regulate the tonus of skeletal muscle (reviewed by Krnjevic 1981; Aprison 1990). Glycinergic synapses prevail in the spinal sensory, auditory, and visual system and in other parts of the CNS.


GABAA Receptor Glycine Receptor Xenopus Laevis Oocyte Spinal Cord Neuron Convulsant Acting 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. Akagi H, Miledi R (1988a) Expression of glycine and other amino acid receptors by rat spinal cord mRNA in Xenopus oocytes. Neurosci Lett 95:262–268PubMedGoogle Scholar
  2. Akagi H, Miledi R (1988b) Heterogeneity of glycine receptors and their messenger RNAs in rat brain and spinal cord. Science 242:270–273PubMedGoogle Scholar
  3. Akagi H, Patton DE, Miledi R (1989) Discrimination of heterogenous mRNAs encoding strychnine-sensitive glycine receptors in Xenopus oocytes by antisense oligonucleotides. Proc Natl Acad Sci USA 86:8103–8107PubMedGoogle Scholar
  4. Akagi H, Hirai K, Hishinuma F (1991) Cloning of a glycine receptor subtype expressed in rat brain and spinal cord during a specific period of neuronal development. FEBS Lett 281:160–166PubMedGoogle Scholar
  5. Akaike N, Kaneda M (1989) Glycine-gated chloride current in acutely isolated rat hypothalamic neurons. J Neurophysiol 62:1400–1409PubMedGoogle Scholar
  6. Altschuler RA, Betz H, Parakkal MH, Reeks KA, Wenthold RJ (1986) Identification of glycinergic synapses in the cochlear nucleus through immunocytochemical localization of the postsynaptic receptor. Brain Res 369:316–320PubMedGoogle Scholar
  7. Al Zamil Z, Bagust J, Kerkut G A (1990) Tubocurarine and strychnine block Renshaw cell inhibition in the isolated mammalian spinal cord. Gen Pharmacol 21:499–509PubMedGoogle Scholar
  8. Aprison MH (1990) The discovery of the neurotransmitter role of glycine. In: Ottersen O, Storm-Mathisen V (eds) Glycine neurotransmission. Wiley, Chichester, pp 1–23Google Scholar
  9. Aprison MH, Lipkowitz KB, Simon JR (1987) Identification of a glycine-like fragment on the strychnine molecule. J Neurosci Res 17:209–213PubMedGoogle Scholar
  10. Araki T, Yamano M, Murakami T, Wanaka A, Betz H, Tohyama M (1988) Localization of glycine receptors in the rat central nervous system: an immunocytochemical analysis using monoclonal antibody. Neuroscience 25:613–624PubMedGoogle Scholar
  11. Asanuma A, Horikoshi T, Yanagisawa K, Anzai K, Goto S (1987) The distribution of GABA and glycine response in the mouse brain using Xenopus oocytes. Neurosci Lett 76:87–90PubMedGoogle Scholar
  12. Ascher P, Gachelin G (1967) Rôle du colliculus supérieur dans l’élaboration de réponse motrices à des stimulations visuelles. Brain Res 3:327–342PubMedGoogle Scholar
  13. Barker JL, McBurney RN, Mathers DA (1983) Convulsant-induced depression of amino acid responses in cultured mouse spinal neurones studied under voltage clamp. Br J Pharmacol 80:619–629PubMedGoogle Scholar
  14. Barron SE, Guth PS (1987) Use and limitations of strychnine as a probe in neurotransmission. Trends Pharmacol Sci 8:204–206Google Scholar
  15. Basbaum AI (1988) Distribution of glycine receptor immunoreactivity in the spinal cord of the rat: cytochemical evidence for a differential glycinergic control of lamina I and V nociceptive neurons. J Comp Neurol 278:330–336PubMedGoogle Scholar
  16. Becker C-M (1990) Disorders of the inhibitory glycine receptor: the spastic mouse. FASEB J 4:2767–2774PubMedGoogle Scholar
  17. Becker C-M, Betz H (1987) Strychnine: useful probe or not? Trends Pharmacol Sci 8:379–380Google Scholar
  18. Becker C-M, Hermans-Borgmeyer I, Schmitt B, Betz H (1986) The glycine receptor deficiency of the mutant mouse spastic: evidence for normal glycine receptor structure and localization. J Neurosci 6:1358–1364PubMedGoogle Scholar
  19. Becker C-M, Hoch W, Betz H (1988) Glycine receptor heterogeneity in rat spinal cord during postnatal development. EMBO J 7:3717–3726PubMedGoogle Scholar
  20. Becker C-M, Hoch W, Betz H (1989) Sensitive immunoassay shows selective association of peripheral and integral membrane proteins of the inhibitory glycine receptor complex. J Neurochem 53:124–131PubMedGoogle Scholar
  21. Benavides J, Lopez-Lahoya J, Valdivieso F, Ugarte M (1981) Postnatal development of synaptic glycine receptors in normal and hyperglycinergic rats. J Neurochem 37:315–320PubMedGoogle Scholar
  22. Benavides J, Malgouris A, Flamier A, Tur C, Quarteronet F, Begasset F, Camelin JC, Uzan C, Gueremy C, LeFur G (1984) Biochemical evidence that 2-phenyl- 4[2-(4-piperidinyl)ethyl]quinoline, a quinoline derivative with pure anticonflict properties, is a partial agonist of benzodiazepine receptors. Neuropharmacology 23:1129–1136PubMedGoogle Scholar
  23. Bertolino M, Vicini S (1988) Voltage-dependent block by strychnine of N-methyl-D- aspartic acid-activated cationic channels in rat cortical neurons in culture. Mol Pharmacol 34:98–103PubMedGoogle Scholar
  24. Betz H (1985) The glycine receptor of rat spinàl cord: exploring the site of action of the plant alkaloid strychnine. Angew Chem (Engl) 24:365–370Google Scholar
  25. Betz H (1990) Ligand-gated ion channels in the brain: the amino acid receptor family. Neuron 5:383–392PubMedGoogle Scholar
  26. Betz H, Becker C-M (1988) The mammalian glycine receptor: biology and structure of a neuronal chloride channel protein. Neurochem Int 13:137–146PubMedGoogle Scholar
  27. Beyer C, Roberts LA, Komisaruk BR (1985) Hyperalgesia induced by altered glycinergic activity at the spinal cord. Life Sci 37:875–882PubMedGoogle Scholar
  28. Biscoe TJ, Curtis DR (1967) Strychnine and cortical inhibition. Nature 214:914–915PubMedGoogle Scholar
  29. Biscoe TJ, Duchen MR (1986) Synaptic physiology of spinal motoneurones of normal and spastic mice: an in vitro study. J Physiol (Lond) 379:275–292Google Scholar
  30. Bormann J, Hamill OP, Sakmann B (1987) Mechanism of anion permeation through channels gated by glycine and γ-aminobutyric acid in mouse cultured spinal cord neurons. J Physiol (Lond) 385:243–286Google Scholar
  31. Braestrup C, Nielsen M (1985) Interaction of pitrazepin with the GABA/ benzodiazepine receptor complex and with glycine receptors. Eur J Pharmacol 118:115–121PubMedGoogle Scholar
  32. Braestrup C, Nielsen M, Krogsgaard-Larsen P (1986) Glycine antagonists structurally related to 4,5,6,7-tetrahydroisoxazolo-[5,4-c]pyridin-3-ol inhibit binding of [3H]strychnine to rat brain membranes. J Neurochem 47:691–696PubMedGoogle Scholar
  33. Brehm L, Krogsgaard-Larsen P, Schaumburg K, Johansen JS, Falch E (1986) Glycine antagonists. Synthesis, structure, and biological effects of some bicyclic 5-isoxazolol zwitterions. J Med Chem 29:224–229PubMedGoogle Scholar
  34. Bristow DR, Bowery NG, Woodruff GN (1986) Light microscopic autoradiographic localisation of [3H]glycine and [3H]strychnine binding sites in rat brain. Eur J Pharmacol 126:303–307PubMedGoogle Scholar
  35. Bruning G, Bauer R, Baumgarten HG (1990) Postnatal development of [3H]flunitrazepam and [3H]strychnine binding sites in rat spinal cord localized by quantitative autoradiography. Neurosci Lett 110:6–10PubMedGoogle Scholar
  36. Carpenter MK, Parker I, Miledi R (1988) Expression of GABA and glycine receptors by messenger RNAs from the developing rat cerebral cortex. Proc R Soc Lond [Biol] 234:159–170Google Scholar
  37. Celentano JJ, Gibbs TT, Farb DH (1988) Ethanol potentiates GABA- and glycine- induced chloride currents in chick spinal cord neurons. Brain Res 455:377–380PubMedGoogle Scholar
  38. Chiavarelli S, Fennoy LV, Settimj G, DeBarran L (1962) The effect of methoxyphenyl substitutions on the strychnine-like activity of arylazaadamantanes and aryldiazaadamantanols. J Med Chem 5:1293–1297Google Scholar
  39. Choquet D, Korn H (1988) Does ß-alanine activate more than one chloride channel associated receptor? Neurosci Lett 84:329–334PubMedGoogle Scholar
  40. Chung E, van Woert MH (1984) DDT myoclonus: sites and mechanism of action. Exp Neurol 85:273–282PubMedGoogle Scholar
  41. Chung EY, van Woert MH (1986) Urea myoclonus: possible involvement of glycine. Adv Neurol 43:565–568PubMedGoogle Scholar
  42. Chung E, Yocca F, van Woert MH (1985) Urea-induced myoclonus: medullary glycine antagonism as mechanism of action. Life Sci 36:1051–1058PubMedGoogle Scholar
  43. Curtis DR, Johnston GAR (1970) Amino acid Transltters in the mammalian central nervous system. Ergeb Physiol 69:98–188Google Scholar
  44. Curtis DR, Malik R (1985) Glycine antagonism by RU 5135. Eur J Pharmacol 110:383–384PubMedGoogle Scholar
  45. Curtis DR, Hösli L, Johnston GAR, Johnston IH (1968a) The hyperpolarization of spinal motoneurones by glycine and related amino acids. Exp Brain Res 5:235–258PubMedGoogle Scholar
  46. Curtis DR, Hösli L, Johnston GAR (1968b) A pharmacological study of the depression of spinal neurones by glycine and related amino acids. Exp Brain Res 6:1–18PubMedGoogle Scholar
  47. Curtis DR, Dugan AW, Johnston GAR (1971a) The specificity of strychnine as a glycine antagonist in the mammalian spinal cord. Exp Brain Res 12:547–565PubMedGoogle Scholar
  48. Curtis DR, Duggan AW, Felix D, Johnston, GAR (1971b) Bicuculline, an antagonist of GABA and synaptic inhibition in the spinal cord of the cat. Brain Res 32:69–96PubMedGoogle Scholar
  49. Davidoff RA, Aprison MH (1969) Picrotoxin antagonism of the inhibition of interneurons by glycine. Life Sci 8:107–112PubMedGoogle Scholar
  50. Dengler R. (1990) The motor unit: physiology, diseases, regeneration. Urban and Schwarzenberg, MunichGoogle Scholar
  51. Drexler G, Sieghart W (1984) Properties of a high affinity binding site for [3H]avermectin Bla. Eur J Pharmacol 99:269–277PubMedGoogle Scholar
  52. Drummond J, Johnson G, Nickell DG, Ortwine DF, Bruns RF, Welbaum B (1989) Evaluation and synthesis of aminohydroxyisoxazoles and pyrazoles as potential glycine agonists. J Med Chem 32:2116–2128PubMedGoogle Scholar
  53. Dusser de Barenne, JG (1933) The mode and site of action of strychnine on the nervous system. Physiol Rev 13:325–335Google Scholar
  54. Eccles JC (1964) The physiology of synapses. Springer, Berlin Heidelberg New YorkGoogle Scholar
  55. Enna SJ, Möhler H (1987) γ-Aminobutyric acid (GABA) receptors and their association with benzodiazepine recognition sites. In: Meitzer HY (ed) Psychopharmacology: the third generation of progress. Raven, New York pp 265–272Google Scholar
  56. Erdö SL (1990) Strychnine protection against excitotoxic cell death in primary cultures of rat cerebral cortex. Neurosci Lett 115:341–344PubMedGoogle Scholar
  57. Evans RH (1978) The effect of amino acids and antagonists on the isolated hemisected spinal cord of the immature rat. Br J Pharmacol 62:171–176PubMedGoogle Scholar
  58. Faingold CL, Hoffmann, WE, Caspary, D.M. (1985) Mechanisms of sensory seizures: brain-stem neuronal response changes and convulsant drugs. Fed Proc 44:2436–2441PubMedGoogle Scholar
  59. Ferenci P, Pappas SC, Munson PJ, Heenson K, Jones EA (1984) Changes in the status of neurotransmitter receptors in a rabbit model of hepatic encephalopathy. Hepatology 4:186–191PubMedGoogle Scholar
  60. Franz DN (1985) Central nervous system stimulants. In: Goodman Gilman A, Goodman LS, Rall TW, Murad F (eds) The pharmacological basis of therapeutics, 7th edn. MacMillan, New York, pp 582–588Google Scholar
  61. Fritz LC, Wang CC, Gorio A (1979) Avermectin Bla irreversibly blocks postsynaptic potentials at the lobster neuromuscular junction by reducing muscle membrane resistance. Proc Natl Acad Sci U.S.A. 76:2062–2066PubMedGoogle Scholar
  62. Frostholm A, Rotter A (1985) Glycine receptor distribution in mouse CNS: autoradiographic localization of [3H]strychnine binding sites. Brain Res Bull 15:473–486PubMedGoogle Scholar
  63. Frostholm A, Rotter A (1986) Autoradiographic localization of receptors in the cochlear nucleus of the mouse. Brain Res Bull 16:189–203PubMedGoogle Scholar
  64. Fry JP, Phelan PP (1985) Interaction of glycine receptor ligands in the normal mouse spinal cord. J Physiol 373:21Google Scholar
  65. Gähwiler BH, Maurer R, Wuthrich HJ (1984) Pitrazepin, a novel GABAa antagonist. Neurosci Lett 45:311–316PubMedGoogle Scholar
  66. Galli A, Nocchi M, Sciarra P (1983) Evidence of enrichment in glycine receptors of crude synaptic membranes from rat spinal cord following Triton X-100 treatment. Biochem Biophys Res Commun 112:809–816PubMedGoogle Scholar
  67. Garcia-Calvo M, Ruiz-Gomez A, Vazquez J, Morato E, Valdivieso F, Mayor F Jr (1989) Functional reconstitution of the glycine receptor. Biochemistry 28:6405–6409PubMedGoogle Scholar
  68. Geyer SW, Gudden W, Betz H, Gnahn H, Weindl A (1987) Co-localization of choline acetyltransferase and postsynaptic glycine receptors in motoneurons of rat spinal cord demonstrated by immunocytochemistry. Neurosci Lett 82:11–15PubMedGoogle Scholar
  69. Gillberg PG, Aquilonius SM (1985) Cholinergic, opioid and glycine receptor binding sites localized in human spinal cord by in vitro autoradiography. Changes in amyotrophic lateral sclerosis. Acta Neurol Scand 72:299–306PubMedGoogle Scholar
  70. Glendenning KK, Baker BN (1988) Neuroanatomieal distribution of receptors for three potential inhibitory neurotransmitters in the brainstem auditory nuclei of the cat. J Comp Neurol 275:288–308PubMedGoogle Scholar
  71. Goldinger A, Müller WE (1980) Stereospecific interaction of bicucculline with specific [3H]strychnine binding to the glycine receptor of rat spinal cord. Neurosci Lett 16:91–95PubMedGoogle Scholar
  72. Goldinger A, Müller WE, Wollert U (1981) Inhibition of glycine and GABA receptor binding by several opiate agonists and antagonists. Gen Pharmacol 12: 477–479PubMedGoogle Scholar
  73. Gosselin RE, Hodge HC, Smith RP, Gleason MN (1976) Clinical toxicology of commercial products, 4th edn. Williams and Wilkins, Baltimore, pp 303–307Google Scholar
  74. Graham D, Pfeiffer F, Betz H (1981) UV-light induced cross-linking of strychnine to the glycine receptor of rat spinal cord membranes. Biochem Biophys Res Commun 102:1330–1335PubMedGoogle Scholar
  75. Graham D, Pfeiffer F, Betz H (1982) Avermectin Bla inhibits the binding of strychnine to the glycine receptor of rat spinal cord. Neurosci Lett 29:173–176PubMedGoogle Scholar
  76. Graham D, Pfeiffer F, Betz H (1983) Photoaffinity-labelling of the glycine receptor of rat spinal cord. Eur J Biochem 131:519–525PubMedGoogle Scholar
  77. Graham D, Pfeiffer F, Simler R, Betz H (1985) Purification and characterization of the glycine receptor of pig spinal cord. Biochemistry 24:990–994PubMedGoogle Scholar
  78. Grenningloh G, Rienitz A, Schmitt B, Methfessel C, Zensen M, Beyreuther K, Gundelfinger ED, Betz H (1987a) The strychnine-binding subunit of the glycine receptor shows homology with nicotinic acetylcholine receptors. Nature 328:215–220PubMedGoogle Scholar
  79. Grenningloh G, Gundelfinger E, Schmitt B, Betz H, Darlison MG, Barnard EA, Schofield PR, Seeburg PH (1987b) Glycine vs GABA receptors (Letter). Nature 330:25–26PubMedGoogle Scholar
  80. Grenningloh G, Schmieden V, Schofield P, Seeburg PH, Siddique T, Mohandas T K, Becker C-M, Betz H (1990a) Alpha subunit variants of the human glycine receptor: primary structures, functional expression and chromosomal localization of the corresponding genes. EMBO J 9:771–776PubMedGoogle Scholar
  81. Grenningloh G, Pribilla I, Prior P, Multhaup G, Beyreuther K, Taleb O, Betz H (1990b) Cloning and expression of the 58 kd beta subunit of the inhibitory glycine receptor. Neuron 4:963–970PubMedGoogle Scholar
  82. Gundersen CB, Miledi R, Parker I (1984) Properties of human brain glycine receptors expressed in Xenopus oocytes. Proc R Soc Lond [Biol] 221:235–244Google Scholar
  83. Gundlach, AL (1990) Disorder of the inhibitory glycine receptor: inherited myoclonus in Hereford calves. FASEB J 4:2761–2766PubMedGoogle Scholar
  84. Gundlach AL, Beart PM (1981) [3H]Strychnine binding suggests glycine receptors in the ventral tegmental area of rat brain. Neurosci Lett 22:289–294Google Scholar
  85. Heidrich H, Ibe K, Klinge D (1969) Akute Vergiftung mit Strychnin-N- oxydhydrochlorid (Movellan-Tabletten(r)) und ihre Behandlung mit Diazepam. Arch Toxicol 24:188–200Google Scholar
  86. Hershenson MF, Prodan KA, Kochman RL, Bloss JL, Mackerer CR (1977) Synthesis of ß-spiro[pyrrolodinoindolines], their binding to the glycine receptor, and in vivo biological activity. J Med Chem 20:1448–1451PubMedGoogle Scholar
  87. Hill RG, Simmonds MA, Straughan DW (1973) Artiino acid antagonists and the depression of cuneate neurones by γ-aminobutyrié acid (GABA) and glycine. Br J Pharmacol 47:642–643Google Scholar
  88. Hill RG, Simmonds MA, Straughan DW (1976) Antagonism of γ-aminobutyric acid and glycine by convulsants in the cuneate nucleus of cat. Br J Pharmacol 56:9–19PubMedGoogle Scholar
  89. Hirsch JA, Oertel D (1988) Synaptic connections in the dorsal cochlear nucleus of mice, in vitro. J Physiol (Lond) 396:549–562Google Scholar
  90. Hoch H, Betz H, Becker C-M (1989) Primary cultures of mouse spinal cord express the neonatal isoform of the inhibitory glycine receptor. Neuron 3:339–348PubMedGoogle Scholar
  91. Horikoshi T, Asanuma A, Yanagisawa K, Anzai K, Goto S (1988a) Taurine and ß-alanine act on both GABA and glycine receptors in Xenopus oocytes injected with mouse brain messenger RNA. Brain Res 464:97–105PubMedGoogle Scholar
  92. Horikoshi T, Asanuma A, Yanagisawa K, Goto S (1988b) Taurine modulates glycine response in Xenopus oocytes injected with messenger RNA from mouse brain. Brain Res 464:243–246PubMedGoogle Scholar
  93. Houamed KM, Bilbe G, Smart TG, Constanti A, Brown DA, Barnard EA, Richards BM (1984) Expression of functional GABA, glycine and glutamate receptors in Xenopus oocytes injected with rat brain mRNA. Nature 310:318–321PubMedGoogle Scholar
  94. Hunt P, Clemens-Jewery S (1981) A steroid derivative, R 5135, antagonizes the GABA/benzodiazepine receptor interaction. Neuropharmacology 20:357–361PubMedGoogle Scholar
  95. Jackson G, Diggle GE, Bourke IG (1971) Strychnine poisoning treated successfully with diazepam. Br Med J 3:519–520PubMedGoogle Scholar
  96. Jaffe JH, Martin WR (1990) Opioid analgesics and antagonists. In: Goodman Gilman A, Rail TW, Nies AS, Taylor P (eds) The pharmacological basis of therapeutics, 8th edn. Pergamon, New York, pp 485–521Google Scholar
  97. Jäger J, Wässle H (1987) Localization of glycine uptake and receptors in the cat retina. Neurosci Lett 75:147–151PubMedGoogle Scholar
  98. Karschin A, Wässle H (1990) Voltage and transmitter-gated currents in isolated rod bipolar cells of the retina. J Neurophysiol 63:860–876PubMedGoogle Scholar
  99. Kehne JH, Davis M (1984) Strychnine increases acoustic startle amplitude but does not alter short-term or long-term habituation. Behav Neurosci 98:955–968PubMedGoogle Scholar
  100. Krishtal OA, Osipchuk YV, Vrublevsky SV (1988) Properties of glycine-activated conductances in rat brain neurones. Neurosci Lett 84:271–276PubMedGoogle Scholar
  101. Krnjevic K (1981) Transmitters in motor systems. In: Geiger SR (ed) Handbook of physiology. Am Physiol Soc, Baltimore, pp 107–154Google Scholar
  102. Krogsgaard-Larsen P, Johnston GAR, Curtis DR, Game CJA, McCulloch RM (1975) Structure and biological activity of a series of conformationally restricted analogues of GABA. J Neurochem 25:803–809PubMedGoogle Scholar
  103. Krogsgaard-Larsen P, Hjeds H, Curtis DR, Leah JD, Peet MJ (1982) Glycine antagonists structurally related to muscimol, THIP, or isoguvacine. J Neurochem 39:1319–1324PubMedGoogle Scholar
  104. Kuhse J, Schmieden V, Betz H (1990a) A single amino acid exchange alters the pharmacology of neonatal rat glycine receptor subunit. Neuron 5:867–873PubMedGoogle Scholar
  105. Kuhse J, Schmieden V, Betz H (1990b) Identification and functional expression of a novel ligand binding subunit of the inhibitory glycine receptor. J Biol Chem 265:22317–22320PubMedGoogle Scholar
  106. Kuhse J, Kuryatov A, Maulet Y, Malosio M-L, Schmieden V, Betz H (1991) Alternative splicing generates two isoforms of the inhibitory glycine receptor. FEBS Lett 283:73–77PubMedGoogle Scholar
  107. Langosch D, Thomas L, Betz H (1988) Conserved quaternary structure of ligand- gated ion channels: the postsynaptic glycine receptor is a pentamer. Proc Natl Acad Sci USA 85:7394–7398PubMedGoogle Scholar
  108. Langosch D, Betz H, Becker C-M (1990a) Molecular structure and developmental regulation of the inhibitory glycine receptor. In: Ottersen O, Storm-Mathisen V (eds) Glycine neurotransmission. Wiley, Chichester, pp 67–82Google Scholar
  109. Langosch D, Becker C-M, Betz H (1990b) The inhibitory glycine receptor: ligand- gated chloride channel of the central nervous system. Eur J Biochem 194:1–8PubMedGoogle Scholar
  110. Langosch D, Hartung K, Grell E, Bamberg E, Betz H (1991) Ion channel formation by synthetic transmembrane segments of the inhibitory glycine receptor-a model study. Biochim Biophys Acta 1063:36–44PubMedGoogle Scholar
  111. LeFort D, Henke H, Cuenod M (1978) Glycine specific [3H]strychnine binding in the pigeon CNS. J Neurochem 30:1287–1291PubMedGoogle Scholar
  112. Lewis CA, Ahmed Z, Faber DS (1989) Characteristics of glycine-activated conductances in cultured medullary neurons from embryonic rat. Neurosci Lett 96:185–190PubMedGoogle Scholar
  113. Lloyd KG, de Montis G, Javoy-Agid F, Beaumont K, Lowenthal A, Constantinidis J, Agid Y (1983a) Glycine receptors in the human brain: characterization of 3H-strychnine binding and status in pathological conditions. Adv Biochem Psychopharmacol 36:233–238PubMedGoogle Scholar
  114. Lloyd KG, de Montis G, Broekkamp CL, Thuret F, Worms P (1983b) Neurochemical and neuropharmacological indications for the involvement of GABA and glycine receptors in neuropsychiatric disorders. Adv Biochem Psychopharmacol 37:137–148PubMedGoogle Scholar
  115. Long SK, Evans RH, Krijzer F (1989) Effects of depressant amino acids and antagonists on an in vitro spinal cord preparation from the adult rat. Neuropharmacology 28:683–688PubMedGoogle Scholar
  116. Longo VG, Silvestrini B, Bovert D (1959) An investigation of convulsant properties of the 5–7-diphenyl-l-3-diazaadamantan-6-ol (1757 I.S.) J Pharmacol Exp Ther 126:41–49PubMedGoogle Scholar
  117. Mackerer CR, Kochman RL, Shen TF, Hershenson FM (1977) The binding of strychnine and strychnine analogs to synaptic membranes of rat brainstem and spinal cord. J Pharmacol Exp Ther 201:326–331PubMedGoogle Scholar
  118. Maksay G (1990) Dissociation of muscimol, SR 95531, and strychnine from GABA A and glycine receptors, respectively, suggests similar cooperative interactions. J Neurochem 54:1961–1966PubMedGoogle Scholar
  119. Malosio M-L, Grenningloh G, Kuhse J, Schmieden V, Schmitt B, Prior P, Betz H (1991a) Alternative splicing generates two variants of the alpha 1 subunit of the inhibitory glycine receptor. J Biol Chem 266:2048–2053PubMedGoogle Scholar
  120. Malosio M-L, Marquèze-Poney B, Kuhse J, Betz H (1991b) Widespread expression of glycine receptor subunit mRNAs in the adult and developing rat brain. EMBO J 10:2401–2409PubMedGoogle Scholar
  121. Marvizón JC, Skolnick P (1988a) Enhancement of t-[35S]butylbicyclophosphoro thionate and [3H]strychnine binding by monovalent anions reveals similarities between γ-aminobutyric acid- and glycine-gated chloride channels. J Neurochem 50:1632–1639PubMedGoogle Scholar
  122. Marvizón JC, Skolnick P (1988b) Anion regulation of [3H]strychnine binding to glycine-gated chloride channels is explained by the presence of two anion binding sites. Mol Pharmacol 34:806–813PubMedGoogle Scholar
  123. Marvizón JC, Vazquez J, Garcia-Calvo M, Mayor F Jr, Ruiz-Gomez A, Valdivieso F, Benavides J (1986a) The glycine receptor: pharmacological studies and mathematical modeling of the allosteric interaction between the glycine- and strychnine-binding sites. Mol Pharmacol 30:590–597PubMedGoogle Scholar
  124. Marvizón JC, Garcia-Calvo M, Vazquez J, Mayor F Jr, Ruiz-Gomez A, Valdiviesco F, Benavides J (1986b) Activation and inhibition of 3H-strychnine binding to the glycine receptor by Eccles’ anions: modulatory effects of cations. Mol Pharmacol 30:598–602PubMedGoogle Scholar
  125. McNamara D, Dingledine R (1990) Dual effect of glycine on NMDA-induced neurotoxicity in rat cortical cultures. J Neurosci 10:3970–3976PubMedGoogle Scholar
  126. Michaud JC, Mienville JM, Chambon JP, Biziere K (1986) Interactions between three pyridazinyl-GABA derivatives and central GABA and glycine receptors in the rat, an in vivo microiontophoretic study. Neuropharmacology 25:1197–1203PubMedGoogle Scholar
  127. Monaghan DT, Bridges RJ, Cotman CW (1989) The excitatory amino acid receptors: their classes, pharmacology, and distinct properties in the function of the central nervous system. Annu Rev Pharmacol Toxicol 29:365–402PubMedGoogle Scholar
  128. Müller WE, Snyder SH (1978) Strychnine binding associated with synaptic glycine receptors in rat spinal cord membranes: ionic influences. Brain Res 147:107–116PubMedGoogle Scholar
  129. Müller F, Wässle H, Voigt T (1988) Pharmacological modulation of the rod pathway in the cat retina. J Neurophysiol 59:1657–1672PubMedGoogle Scholar
  130. Naas E, Zilles K, Gnahn H, Betz H, Becker C-M, Schröder H (1991) Glycine receptor immunoreactivity in rat and human cerebral cortex. Brain Res 561: 139–146PubMedGoogle Scholar
  131. Nicholson GM, Spence I, Johnston GAR (1988) Differing actions of convulsant and nonconvulsant barbiturates: an electrophysiological study in the isolated spinal cord of the rat. Neuropharmacology 27:459–465PubMedGoogle Scholar
  132. Obata K, Highstein SM (1970) Blocking by picrotoxin of both vestibular inhibition and GABA action on rabbit oculomotor neurons. Brain Res 18:538–541PubMedGoogle Scholar
  133. O’Connor VM (1989) Chemical modification of overlapping but conformationally distinct recognition sites for glycine and strychnine in isolated spinal cord membranes. J Physiol (Lond) 415:49 PGoogle Scholar
  134. Olsen RW, Tobin AJ (1990) Molecular biology of GABAa receptors. FASEB J 4:1469–1480PubMedGoogle Scholar
  135. Ondo JG, Buckholtz NS (1983) The central actions of glycine and strychnine on prolactin and LH secretion. Brain Res Bull 11:7–10PubMedGoogle Scholar
  136. Parker I, Sumidawa K, Miledi R (1985) Messenger RNA from bovine retina induces kainate and glycine receptors in Xenopus oocytes. Proc R Soc Lond [Biol] 225:99–106Google Scholar
  137. Parker I, Sumikawa K, Miledi R (1988) Responses to GABA, glycine and ß-alanine induced in Xenopus oocytes by messenger RNA from chick and rat brain. Proc R Soc Lond [Biol] 233:201–216Google Scholar
  138. Perper JA (1985) Fatal strychnine poisoning - a case report and review of the literature. J Forensic Sci 30:1248–1255PubMedGoogle Scholar
  139. Pfeiffer F, Betz H (1981) Solubilization of the glycine receptor from rat spinal cord. Brain Res 226:273–279PubMedGoogle Scholar
  140. Pfeiffer F, Graham D, Betz H (1982) Purification by affinity chromatography of the glycine receptor of rat spinal cord. J Biol Chem 257:9389–9393PubMedGoogle Scholar
  141. Pfeiffer F, Simler R, Grenningloh G, Betz H (1984) Monoclonal antibodies and peptide mapping reveal structural similarities between the subunits of the glycine receptor of rat spinal cord. Proc Natl Acad Sci USA 81:7224–7227PubMedGoogle Scholar
  142. Phelan PP, Fry JP, Martin IL, Johnston GAR (1989) Polyclonal antibodies to the glycine receptor antagonist strychnine. J Neurochem 52:1481–1486PubMedGoogle Scholar
  143. Poulsson E (1920) Die Strychningruppe. In: Hefftner A (ed) Handbuch der Experimentellen Pharmakologie, vol 2. Springer, BerlinGoogle Scholar
  144. Probst A, Cortes R, Palacios JM (1986) The distribution of glycine receptors in the human brain. A light microscopic autoradiographic study using [3H]strychnine. Neuroscience. 17:11–35PubMedGoogle Scholar
  145. Rees R, Smith H (1967) Structure and biological activity of some reduction products of strychnine, brucine, and their congeners. J Med Chem 10:624–627Google Scholar
  146. Rienitz A, Becker C-M, Betz H, Schmitt B (1987) The chloride channel blocking agent, t-butyl bicyclophosphorothionate, binds to the gamma-aminobutyric acid- benzodiazepine, but not to the glycine receptor in rodents. Neurosci Lett 76:91–95PubMedGoogle Scholar
  147. Riquelme G, Morato E, Lopez E, Ruiz-Gomez A, Ferragut JA, Gonzalez-Ros JM, Mayor F Jr (1990) Agonist binding to purified glycine receptor reconstituted into giant liposomes elicits two types of chloride currents. FEBS Lett 276: 54–58PubMedGoogle Scholar
  148. Rote Liste (1991) Cantor, AulendorfGoogle Scholar
  149. Rotter A, Schultz CM, Frostholm A (1984) Regulation of glycine receptor binding in the mouse hypoglossal nucleus in response to axotomy. Brain Res Bull 13:487–492PubMedGoogle Scholar
  150. Ruiz-Gomez A, Fernandez-Shaw C, Valdivieso F, Mayor F Jr (1989a) Chemical modification of the glycine receptor with fluorescein isothiocyanate specifically affects the interaction of glycine with its binding site. Biochem Biophys Res Commun 160:374–381PubMedGoogle Scholar
  151. Ruiz-Gómez A, Garcia-Calvo M, Vazquez J, Marvizòn JC, Valdivieso F, Mayor F Jr (1989b) Thermodynamics of agonist and antagonist interaction with the strychnine-sensitive glycine receptor. J Neurochem 52:1775–1780PubMedGoogle Scholar
  152. Ruiz-Gómez A, Morato E, Garcia-Calvo M, Valdivieso F, Mayor F Jr (1990) Localization of the strychnine binding site on the 48-kilodalton subunit of the glycine receptor. Biochemistry 29:7033–7040PubMedGoogle Scholar
  153. Ruiz-Gómez A, Vaello ML, Valdivieso F, Mayor F Jr (1991a) Phosphorylation of the 48-kDa subunit of the glycine receptor by protein kinase C. J Biol Chem 266:559–566PubMedGoogle Scholar
  154. Ruiz-Gómez A, Fernandez-Shaw C, Morato E, Marvizòn JC, Vazquez J, Valdivieso F, Mayor F Jr (1991b) Sulfhydryl groups modulate the allosteric interaction between glycine binding sites at the inhibitory glycine receptor. J Neurochem 56:1690–1697PubMedGoogle Scholar
  155. Ryan GP, Hackman JC, Davidoff, RA (1984) Spinal seizures and excitatory amino acid-mediated synaptic transmission. Neurosci Lett 44:161–166PubMedGoogle Scholar
  156. Sanes DH, Wooten GF (1987) Development of glycine receptor distribution in the lateral superior olive of the gerbil. J Neurosci 7:3803–3811PubMedGoogle Scholar
  157. Sanes DH, Geary WA, Wooten GF, Rubel EW (1987) Quantitative distribution of the glycine receptor in the auditory brain stem of the gerbil. J Neurosci 7:3793–3802PubMedGoogle Scholar
  158. Schaeffer JM, Anderson SM (1981) Identification of strychnine binding sites in the rat retina. J Neurochem 36:1597–1600PubMedGoogle Scholar
  159. Schaffner AE, St John PA, Barker JL (1987) Fluorescence-activated cell sorting of embryonic mouse and rat motoneurons and their long-term survival in vitro. J Neurosci 7:3088–3104PubMedGoogle Scholar
  160. Schmieden V, Grenningloh G, Schofield PR, Betz H (1989) Functional expression in Xenopus oocytes of the strychnine binding 48 kd subunit of the glycine receptor. EMBO J 8:695–700PubMedGoogle Scholar
  161. Schmitt B, Knaus P, Becker C-M, Betz H (1987) The Mr 93000 polypeptide of the postsynaptic glycine receptor is a peripheral membrane protein. Biochemistry 26:805–811PubMedGoogle Scholar
  162. Schröder S, Hoch W, Becker C-M, Grenningloh G, Betz H (1991) Mapping of antigenic epitopes on the α1 subunit of the inhibitory glycine receptor. Biochemistry 30:42–47PubMedGoogle Scholar
  163. Sigel E, Baur R (1988) Effect of avermectin Bla on chick neuronal γ-aminobutyrate receptor channels expressed in Xenopus oocytes. Mol Parmacol 32:749–752Google Scholar
  164. Simmonds MA (1983) Depolarizing responses to glycine, beta-alanine and muscimol in isolated optic nerve and cuneate nucleus. Br J Pharmacol 79:799–806PubMedGoogle Scholar
  165. Simmonds MA (1986) Classification of inhibitory amino acid receptors in the mammalian nervous system. Med Biol 64:301–311PubMedGoogle Scholar
  166. Smith EB, Bowser-Riley F, Daniels S, Dunbar IT, Harrison CB, Paton WB (1984) Species variation and the mechanism of pressure-anaesthetic interactions. Nature 311:56–57PubMedGoogle Scholar
  167. Song YM, Huang LY (1990) Modulation of glycine receptor chloride channels by cAMP-dependent protein kinase in spinal trigeminal neurons. Nature 348:242–245PubMedGoogle Scholar
  168. Sontheimer H, Becker C-M, Pritchett DP, Schofield PR, Grenningloh G, Kettenmann H, Betz H, Seeburg PH (1989) Functional chloride channels by mammalian cell expression of rat glycine receptor subunit. Neuron 2:1491–1497PubMedGoogle Scholar
  169. Squires RF, Casida JE, Richardson M, Saedrup E (1983) [55S]t-Butylcyclo- phosphorothionate binds with high affinity to brain specific sites coupled to γ-aminobutyric acid-A and ion recognition sites. Mol Parmacol 23:326–336Google Scholar
  170. Srinivasan Y, Guzikowski AP, Haugland RP, Angelides KJ (1990) Distribution and lateral mobility of glycine receptors on cultured spinal cord neurons. J Neurosci 10:985–995PubMedGoogle Scholar
  171. St John PA, Wayne MK, Mazetta JS, Lange GD, Barker JL (1986) Analysis and isolation of embryonic mammalian neurons by fluorescence-activated cell sorting. J Neurosci 6:1492–1512PubMedGoogle Scholar
  172. Takahashi T (1984) Inhibitory miniature synaptic potentials in rat motoneurons. Proc R Soc Lond [Biol] 221:103–109Google Scholar
  173. Talman WT (1988) Glycine microinjected in the rat dorsal vagal nucleus increases arterial pressure. Hypertension 11:664–667PubMedGoogle Scholar
  174. Talman WT, Robertson SC (1989) Glycine, like glutamate, microinjected into the nucleus tractus solitarii of rat decreases arterial pressure and heart rate. Brain Res 16(477) ;7–13Google Scholar
  175. Teuscher E, Lindeqifist U (1988) Biogene Gifte. Akademie, BerlinGoogle Scholar
  176. Ticku MK, Ban M, Olsen RW (1978) Binding of [3H]a-dihydropicrotoxinin, a γ-aminobutyric acid synaptic antagonist, to rat brain membranes. Mol Pharmacol 14:391–402PubMedGoogle Scholar
  177. Tokutomi N, Kaneda M, Akaike N (1989) What confers specificity on glycine for its receptor site? Br J Pharmacol 97:353–360PubMedGoogle Scholar
  178. Tribble GL, Schwindt PC, Crill WE (1983) Reduction of postsynaptic inhibition tolerated before seizure initiation: spinal cord. Exp Neurol 80:288–303PubMedGoogle Scholar
  179. Triller A, Cluzeaud F, Pfeiffer F, Betz H, Korn H (1985) Distribution of glycine receptors at central syhnapses: an immunoelectron microscopy study. J Cell Biol 101:683–688PubMedGoogle Scholar
  180. Triller A, Cluzeaud F, Korn H (1987) Gamma-aminobutyric acid-containing terminals can be apposed to glycine receptors at central synapses. J Cell Biol 104:947–956PubMedGoogle Scholar
  181. Triller A, Seitanidon T, Franksson O, Korn H (1990) Size and shape of glycine receptor clusters in a central neuron exhibit a somato-dendritic gradient. New Biol 2:637–641PubMedGoogle Scholar
  182. Van den Pol AN, Gores T (1988) Glycine and glycine receptor immunoreactivity in brain and spinal cord. J Neurosci 8:472–492PubMedGoogle Scholar
  183. Von Hippel A (1873) Über die Wirkungen des Strychnins auf das normale und kranke Auge. Springer, BerlinGoogle Scholar
  184. Wenthold RJ, Parakkal MH, Oberdorfer MD, Altschuler RA (1988) Glycine receptor immunoreactivity in the ventral cochlear nucleus of the guinea pig. J Comp Neurol 276:423–435PubMedGoogle Scholar
  185. Werman R, Davidoff RA, Aprison MH (1968) Inhibitory action of glycine on spinal neurons in the cat. Nature 214:681–683Google Scholar
  186. White WF (1985) The glycine receptor in the mutant mouse spastic (spa): strychnine binding characteristics and pharmacology. Brain Res 329:1–6PubMedGoogle Scholar
  187. White WF, O’Gorman S, Roe AW (1990) Three-dimensional autoradiographic localization of quench-corrected glycine receptor specific activity in the mouse brain using 3H-strychnine as the ligand. J Neurosci 10:795–813PubMedGoogle Scholar
  188. Williams M, Risley EA (1982) Interaction of avermectins with [3H]ß-carboline-3- carboxylate ethyl ester and [3H]diazepam binding sites in rat brain cortical membranes. Eur J Pharmacol 77:307–315PubMedGoogle Scholar
  189. Woodward RB, Cava MP, Ollis WD, Hunger A, Daeniker HU, Schenker K (1954) The total synthesis of strychnine. J Am Soc Chem 76:4749–4751Google Scholar
  190. Wu SH, Oertel D (1990) Inhibitory circuitry in the ventral cochlear nucleus is probably mediated by glycine. J Neurosci 6:2691–2706Google Scholar
  191. Yadid G, Youdim MB, Zinder O (1990) High-affinity strychnine binding to adrenal medulla chromaffin cell membranes. Eur J Pharmacol 175:365–366PubMedGoogle Scholar
  192. Yaksh TL (1989) Behavioral and autonomic correlates of the tactile evoked allodynia produced by spinal glycine inhibition: effects of modulatory receptor systems and excitatory amino acid antagonists. Pain 37:111–123PubMedGoogle Scholar
  193. Yaksh TL, Harty GJ (1988) Pharmacology of the allodynia in rats evoked by high dose intrathecal morphine. J Pharmacol Exp Ther 244:501–507PubMedGoogle Scholar
  194. Young AB, Snyder SH (1973) Strychnine binding associated with glycine receptors of the central nervous system. Proc Natl Acad Sci USA 70:2832–2836PubMedGoogle Scholar
  195. Young AB, Snyder SH (1974a) Strychnine binding in rat spinal cord membranes associated with the synaptic glycine receptor: cooperativity of glycine interactions. Mol Pharmacol 10:790–809Google Scholar
  196. Young AB, Snyder SH (1974b) The glycine synaptic receptor: evidence that strychnine binding is associated with the ionic conductance mechanism. Proc Natl Acad Sci USA 71:4002–4005PubMedGoogle Scholar
  197. Young AB, Zukin SR, Snyder SH (1974) Interaction of benzodiazepines with central nervous glycine receptors: possible mechanism of action. Proc Natl Acad Sci USA 71:2246–2250PubMedGoogle Scholar
  198. Zarbin MA, Wamsley JK, Kuhar MJ (1981) Glycine receptor: light microscopic autoradiographic localization with [3H] strychnine. J Neurosci 1:532–547PubMedGoogle Scholar
  199. Zieglgänsberger W, Herz A (1971) Changes of cutaneous receptive fields of spinocervical tract neurones and other dorsal horn neurons by microelectrophoretically administered amino acids. Exp Brain Res 13:111–126PubMedGoogle Scholar
  200. Zukin SR, Young AB, Snyder SH (1975) Development of the synaptic glycine receptor in chick embryo spinal cord. Brain Res 83:525–530PubMedGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 1994

Authors and Affiliations

  • C.-M. Becker

There are no affiliations available

Personalised recommendations